CC BY-NC-ND 4.0 · Annals of Otology and Neurotology 2021; 4(01): 019-025
DOI: 10.1055/s-0041-1735394
Original Article

MRI T2-Weighted Cochlear Intensity as a Predictor of Hearing Loss with Vestibular Schwannoma Patients

Peter Q. Luong
1   Department of Otolaryngology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
,
Claudia I. Cabrera
2   Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
,
Nirav Patil
2   Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
,
Hammad Khan
1   Department of Otolaryngology, Case Western Reserve University School of Medicine, Cleveland, Ohio, United States
,
Carlito Lagman
3   Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
,
Thomas A. Ostergard
3   Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
,
Gary Huang
2   Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
,
Nicholas C. Bambikidas
3   Department of Neurosurgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
,
Sarah E. Mowry
2   Department of Otolaryngology-Head and Neck Surgery, University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States
› Author Affiliations

Abstract

Objective It is difficult to predict how hearing loss will progress with vestibular schwannomas (VSs) and to determine the optimal time for hearing preservation interventions. This study investigated the relationship between cochlear intensity on T2-weighted magnetic resonance imaging and hearing loss in VS patients over time.

Design Retrospective cohort study.

Setting Single major academic center.

Participants Patients with a diagnosis of VS from 2007 to 2018.

Main Outcome Measures Pure tone average (PTA) and cochlear-to-pontine relative signal intensity (RSI) measured at two time points.

Results Fifty patients were included in the final analysis. For both affected and unaffected ears, the trend in PTA increased from baseline to follow-up. For affected ears, the trend in RSI increased from baseline to follow-up, while for the unaffected ears RSI decreased. There was a significant positive correlation between the initial RSI value in the ipsilateral ear when compared with the change in PTA from baseline to follow-up (r = 0.28, p = 0.048).

Conclusion There is a trend between initial RSI and how hearing changes in the affected ears of patients with VS. Additional studies are needed to explore how this relationship may be better used to predict hearing loss.



Publication History

Article published online:
14 September 2021

© 2021. Indian Society of Otology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery 1997; 40 (01) 1-9 discussion 9-10
  • 2 Kondziolka D, Mousavi SH, Kano H, Flickinger JC, Lunsford LD. The newly diagnosed vestibular schwannoma: radiosurgery, resection, or observation?. Neurosurg Focus 2012; 33 (03) E8
  • 3 Lin EP, Crane BT. The management and imaging of vestibular schwannomas. AJNR Am J Neuroradiol 2017; 38 (11) 2034-2043
  • 4 Yoshimoto Y. Systematic review of the natural history of vestibular schwannoma. J Neurosurg 2005; 103 (01) 59-63
  • 5 Kim DY, Lee JH, Goh MJ. et al. Clinical significance of an increased cochlear 3D fluid-attenuated inversion recovery signal intensity on an MR imaging examination in patients with acoustic neuroma. AJNR Am J Neuroradiol 2014; 35 (09) 1825-1829
  • 6 Oghalai JS, Jackler RK. New web-based tool for generating scattergrams to report hearing results. Otolaryngol Head Neck Surg 2016; 154 (06) 981
  • 7 Stangerup SE, Thomsen J, Tos M, Cayé-Thomasen P. Long-term hearing preservation in vestibular schwannoma. Otol Neurotol 2010; 31 (02) 271-275
  • 8 Chiluwal AK, Rothman A, Svrakic M, Dehdashti AR. Surgical outcome in smaller symptomatic vestibular schwannomas. Is there a role for surgery?. Acta Neurochir (Wien 2018; 160 (11) 2263-2275
  • 9 Akpinar B, Mousavi SH, McDowell MM. et al. Early radiosurgery improves hearing preservation in vestibular schwannoma patients with normal hearing at the time of diagnosis. Int J Radiat Oncol Biol Phys 2016; 95 (02) 729-734
  • 10 Nadol Jr JB, Diamond PF, Thornton AR. Correlation of hearing loss and radiologic dimensions of vestibular schwannomas (acoustic Neuromas. Am J Otol 1996; 17 (02) 312-316
  • 11 Tierney PA, Chitnavis BP, Sherriff M, Strong AJ, Gleeson MJ. The relationship between pure tone thresholds and the radiological dimensions of acoustic neuromas. Skull Base Surg 1998; 8 (03) 149-151
  • 12 Silverstein H, Schuknecht HF. Biochemical studies of inner ear fluid in man. Changes in otosclerosis, Meniere's disease, and acoustic neuroma. Arch Otolaryngol 1966; 84 (04) 395-402
  • 13 O'Connor AF, France MW, Morrison AW. Perilymph total protein levels associated with cerebellopontine angle lesions. Am J Otol 1981; 2 (03) 193-195
  • 14 Bhadelia RA, Tedesco KL, Hwang S. et al. Increased cochlear fluid-attenuated inversion recovery signal in patients with vestibular schwannoma. AJNR Am J Neuroradiol 2008; 29 (04) 720-723 DOI: 10.3174/ajnr.A0968.
  • 15 Somers T, Casselman J, de Ceulaer G, Govaerts P, Offeciers E. Prognostic value of magnetic resonance imaging findings in hearing preservation surgery for vestibular schwannoma. Otol Neurotol 2001; 22 (01) 87-94
  • 16 Yamazaki M, Naganawa S, Kawai H, Nihashi T, Fukatsu H, Nakashima T. Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma. Neuroradiology 2009; 51 (12) 855-863
  • 17 Lassaletta L, Calvino M, Morales-Puebla JM. et al. Biomarkers in vestibular schwannoma-associated hearing loss. Front Neurol 2019; 10: 978
  • 18 Roosli C, Linthicum FH Jr, Cureoglu S, Merchant SN. Dysfunction of the cochlea contributing to hearing loss in acoustic neuromas: an underappreciated entity. Otol Neurotol 2012; 33 (03) 473-480
  • 19 Eliezer M, Poillon G, Maquet C. et al. Sensorineural hearing loss in patients with vestibular schwannoma correlates with the presence of utricular hydrops as diagnosed on heavily T2-weighted MRI. Diagn Interv Imaging 2019; 100 (05) 259-268
  • 20 Karch-Georges A, Veillon F, Vuong H. et al. MRI of endolymphatic hydrops in patients with vestibular schwannomas: a case-controlled study using non-enhanced T2-weighted images at 3 Teslas. Eur Arch Otorhinolaryngol 2019; 276 (06) 1591-1599